J.P. Morgan Securities LLC, acting through its affiliate JPMorgan Securities Japan Co., Ltd., acted as exclusive financial advisor to Astellas and Jones Day as Astellas’ legal...
Astellas’ Acquisition of Iveric Bio
GSK’s Acquisition of BELLUS Health
Paul, Weiss, Rifkind, Wharton & Garrison LLP, and Stikeman Elliott LLP advised GSK, while Skadden, Arps, Slate, Meagher & Flom LLP, and Davies Ward Phillips &...
Merck’s Acquisition of Prometheus Biosciences
Paul, Weiss, Rifkind, Wharton & Garrison represented Merck, Latham & Watkins represented Prometheus, Skadden represented the financial advisors on the deal. Prometheus Biosciences, Inc. have entered...
Pfizer’s Acquisition of Seagen
Wachtell, Lipton, Rosen & Katz is acting as Pfizer’s legal advisor. Sullivan & Cromwell is serving as Seagen’s Board of Directors legal advisor. Skadden is advising...
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
Alcon’s Acquisition of Aerie Pharmaceuticals
Skadden, Arps, Slate, Meagher & Flom represented Alcon, while Fried, Frank, Harris, Shriver & Jacobson represented Aerie in the transaction. Alcon entered into a definitive merger...
Vertex’s $320 Million Acquisition of ViaCyte
Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...
Pfizer’s Acquisition of Biohaven Pharmaceutical
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...
Halozyme Therapeutics’ Acquisition of Antares Pharma
Weil, Gotshal & Manges advised Halozyme, while Skadden, Arps, Slate, Meagher & Flom advised Antares Pharma on the deal. Fried Frank acted as counsel to BofA...
Thoma Bravo’s $2.6 Billion Acquisition of Bottomline Technologies
Skadden, Arps, Slate, Meagher & Flom and Wilmer Cutler Pickering Hale and Dorr represented Bottomline, while Kirkland & Ellis represented Thoma Bravo in the transaction. Debevoise...
Novo Nordisk’s Acquisition of Dicerna Pharmaceuticals
Skadden, Arps, Slate, Meagher & Flom advised Dicerna Pharmaceuticals on the deal. Davis Polk & Wardwell advised Evercore. Dicerna Pharmaceuticals, Inc., has entered into a definitive agreement...
AspenTech’s Merger With Emerson Electric Co.’s
Simpson Thacher advised JPMorgan as financial advisor on the deal, while Davis Polk advised Emerson. Skadden, Arps, Slate, Meagher & Flom advised AspenTech. Aspen Technology, Inc....